Stay updated on Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.

Latest updates to the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedVersion history now includes Revision: v3.4.2 added, and the notices about government funding and the earlier Revision: v3.4.1 have been removed. These are administrative updates that do not change study data or user-facing functionality.SummaryDifference0.7%

- Check21 days agoChange DetectedA site-wide funding notice about potential delays in updates was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe history page now includes a glossary display option, and changes are shown with green highlights for additions and red highlights for deletions. The revision line shows v3.4.0 and the No FEAR Act Data item appears in the record.SummaryDifference1.0%

- Check35 days agoChange DetectedThe record history shows a new revision (v3.3.4) replacing the prior (v3.3.3), a minor administrative update that does not alter study content or results; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the history, and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe history shows a new site revision label v3.3.2 added, with the previous v3.3.1 label removed.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.